Filing Flows › Comparisons › AVTX vs NTHI
Avalo Therapeutics vs Neonc Technologies Holdings: AVTX and NTHI compared
Avalo Therapeutics is the larger company: $59K of revenue in its latest quarter (Q4 2025) against $40K for Neonc Technologies Holdings (Q1 2025). Neonc Technologies Holdings is growing faster (-7% against -69% a year earlier).
Where the money goes: AVTX and NTHI
Avalo Therapeutics (AVTX) · Q4 2025
Avalo Therapeutics, Q4 2025: revenue $59K (-69% year over year), net loss $13.7M, operating cash flow −$14.2M. The chart follows the revenue to costs, profit and cash.
Neonc Technologies Holdings (NTHI) · Q1 2025
Neonc Technologies Holdings, Q1 2025: revenue $40K (-7% year over year), net loss $38.0M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.
| Avalo Therapeutics (AVTX) | Neonc Technologies Holdings (NTHI) | |
|---|---|---|
| Latest quarter | Q4 2025 | Q1 2025 |
| Revenue | $59K | $40K |
| Revenue growth, Y/Y | -69% | -7% |
| Operating margin | n/m | n/m |
| Net earnings | −$13.7M | −$38.0M |
| Operating cash flow | −$14.2M | −$5.7M |
| Market value | $595M | — |
| Analysts’ mean target | $36.60 | — |
Questions
Which is bigger, Avalo Therapeutics or Neonc Technologies Holdings?
Avalo Therapeutics is the larger company: $59K of revenue in its latest quarter (Q4 2025) against $40K for Neonc Technologies Holdings (Q1 2025).
Is Avalo Therapeutics or Neonc Technologies Holdings growing faster?
Neonc Technologies Holdings is growing faster (-7% against -69% a year earlier).
More: Avalo Therapeutics earnings · how Avalo Therapeutics makes money · Neonc Technologies Holdings earnings · how Neonc Technologies Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Mar 23, 2026; 10-Q filed May 9, 2025). Fiscal quarters can end on different dates. Not investment advice.